The Scientist - Home

A new study indicates that the modified CRISPR-Cas9 technology will need to be further refined before it can safely be used for research and therapeutic applications.

Fungal researcher Christina Cuomo discusses the spread of infections plaguing hospitals across the world.

Researchers develop a system to deliver synthetic blood to isolated brains hours after death.

Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”

Researchers want to avoid a situation from last week in which a professor, banned from his university for substantiated sexual misconduct claims, showed up at the Society for American Archaeology conference.

One person with multiple myeloma and one with sarcoma are the first so far to receive the genetically engineered T cells in the study.

For primates, males’ fancier ornaments are linked with smaller testes, according to a new comparative study.

The agency also shares preliminary results of an Ebola vaccine trial showing that it is 97.5 percent effective at protecting from infection.

A reporter, slated to speak about sexual harassment, is banned from the Society for American Archaeology conference after he confronts an accused sexual harasser in attendance.

The University of Cambridge and the University of Bristol conducted investigations of the research.

Flupyradifurone, sold as Sivanto, is reported to have greater lethal and sublethal effects on honey bees when combined with a common fungicide.

A study hints that it might be possible to diagnose chronic traumatic encephalopathy, a neurodegenerative disease associated with frequent head injuries, while patients are still living.